Overview Fundamentals API Earnings EOD API Sample Code Pricing

Nyrada Inc (NYR AU) stock market data APIs

A$0.057 0(0%) as of September 20, 2024
Price chart is built with Anychart

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases. Its develops oral Proprotein Convertase Subtilisin/Kexin Type 9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; and neuroprotectant drug to reduce long-term disability in patients with traumatic brain injury and ischaemic stroke. Nyrada Inc. was incorporated in 2017 and is based in Gordon, Australia.

Nyrada Inc Financial Data Overview

0.057
0.057
-
0.057
0.057
0.018-0.165
10 386 K
182 M
3 242 K
1.424
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NYR',
Type: 'Common Stock',
Name: 'Nyrada Inc',
Exchange: 'AU',
CurrencyCode: 'AUD',
CurrencyName: 'Australian Dollar',
CurrencySymbol: 'A$',
CountryName: 'Australia',
CountryISO: 'AU',
OpenFigi: 'BBG00QZ9DRH2',
ISIN: 'AU0000070195',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'June',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Nyrada Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 3 242 K
  • EBITDA -1 547 140
  • Earnings Per Share -0.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Nyrada Inc Earnings via APIs

  • Latest Release 2024-08-22
  • EPS/Forecast NaN

Get Nyrada Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com